Trial intelligence / Profile preview

Gentamicin-Collagen Sponge for Diabetic Foot Infection

NCT02447172Phase 3Completed

Sponsor
Innocoll
Start
Jun 2015
Primary completion
Sep 2016
Modality
Nanoparticles, Implantable Devices, Transdermal Patches
Countries
16
01

Overview

A Phase 3 trial of gentamicin in diabetic foot infection (DFI), sponsored by Innocoll. Started Jun 2015; status: completed.

02

Drugs

gentamicin
03

Conditions

diabetic foot infection (DFI)

Beyond the preview

Go deeper on NCT02447172.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02447172.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call